Skip to main content

Table 1 Characteristics of participants according to the FADS2 rs174583 genotypes

From: Interplay between fatty acid desaturase2 (FADS2) rs174583 genetic variant and dietary antioxidant capacity: cardio-metabolic risk factors in obese individuals

 

Men

Women

 

CC

CT

TT

Pa

CC

CT

TT

Pa

Age (y)

39.06 (7.55)

37.03 (6.34)

41.20 (5.20)

0.168

37.42 (7.20)

37.43 (7.91)

36.50 (8.14)

0.961

Weight (kg)

103.16 (10.26)

101.43 (10.63)

101.59 (14.18)

0.783

88.79 (13.58)

88.64 (12.28)

94.82 (7.50)

0.517

WC (cm)

113.25 (7.11)

112.46 (7.82)

114.00 (10.17)

0.827

102.75 (9.27)

101.38 (9.51)

105.67 (9.18)

0.083

FM (kg)

29.61 (7.19)

28.63 (6.95)

31.16 (8.97)

0.597

38.50 (8.76)

37.90 (8.80)

41.73 (4.34)

0.590

FFM (kg)

73.61 (5.65)

72.82 (6.17)

70.43 (6.51)

0.340

50.30 (5.84)

50.76 (4.53)

53.08 (4.08)

0.473

Appetite

35.29 (10.21)

35.41 (10.24)

31.40 (7.73)

0.503

32.58 (8.95)

31.78 (8.06)

33.50 (8.34)

0.862

Physical activity level, (%)

   

0.921

   

0.225

 Low

40.0

33.3

30.0

 

62.5

57.1

100.0

 

 Moderate

25.7

38.5

40.0

 

16.7

31.0

0.0

 

 High

34.3

28.2

30.0

 

20.8

11.9

0.0

 

Marital status, (%)

   

0.844

   

0.569

 Married

82.9

82.1

80.0

 

79.2

90.5

83.3

 

 Single

17.1

17.9

20.0

 

20.8

9.5

16.7

 

SES, (%)

   

0.973

   

0.827

 Low

0.0

0.0

0.0

 

4.2

7.1

0.0

 

 Middle

38.2

25.6

50.0

 

83.3

76.2

83.3

 

 High

61.8

74.4

50.0

 

12.5

16.7

16.7

 

Stress, (%)

   

0.663

   

0.501

 Normal

48.6

38.5

40.0

 

29.2

33.3

50.0

 

 Mild

5.7

7.7

10.0

 

20.8

14.3

16.7

 

 Moderate

17.1

23.1

20.0

 

33.3

28.6

33.3

 

 Severe

17.1

15.4

20.0

 

12.5

23.8

0.0

 

 Extremely severe

11.4

15.4

10.0

 

4.2

0.0

0.0

 

Anxiety, (%)

   

0.666

   

0.250

 Normal

48.6

38.5

40.0

 

45.8

21.4

16.7

 

 Mild

5.8

7.6

10.0

 

12.5

11.9

16.7

 

 Moderate

17.1

23.1

20.0

 

16.7

31.0

50.0

 

 Severe

17.1

15.4

20.0

 

8.3

14.3

16.7

 

 Extremely-severe

11.4

15.4

10.0

 

16.7

21.4

0.0

 

Depression, (%)

   

0.104

   

0.431

 Normal

45.7

53.8

80.0

 

29.2

35.7

50.0

 

 Mild

8.6

12.8

10.0

 

12.5

19.0

0.0

 

 Moderate

28.6

20.5

0.0

 

25.0

26.2

33.3

 

 Severe

8.6

7.7

0.0

 

25.0

7.1

0.0

 

 Extremely severe

8.6

5.1

10.0

 

8.3

11.9

16.7

 

ORAC (µmol TE/d)

16,177.95 (12,781.03, 23,482.19)

17,133.49 (12,591.73, 23,604.74)

19,642.65 (9,936.24, 37,167.90)

0.948

24,658.08 (14,030.06, 29,422.07)

20,017.15 (16,051.33, 29,259.28)

19,565.08 (15,060.64, 28,376.06)

0.788

FRAP (mmol Fe+2/d)

36.95 (16.49)

38.47 (18.69)

43.36 (16.95)

0.733

47.87 (20.43)

45.07 (18.84)

45.95 (10.61)

0.813

TRAP (mmol TE/d)

24.89 (15.86, 30.73)

23.32 (15.85, 38.23)

27.03 (15.54, 43.58)

0.816

31.89 (13.29)

31.42 (15.18)

29.27 (7.86)

0.868

  1. Data are presented as mean (SD) or median (25 and 75 percentiles). aAnalysis of variance for continuous variables and χ2 test for categorical variables. WC Waist circumference, SES Socio-economic status, FM Fat mass, FFM Fat free mass, FADS Fatty acid desaturase, ORAC Oxygen Radical Absorbance Capacity, FRAP Ferric Reducing Ability of Plasma, TRAP Total Radical-Trapping Antioxidant Parameter
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us